High-Purity Boc-(R)-3-Amino-4-(4-bromophenyl)-butyric Acid: Your Key Pharmaceutical Intermediate

Discover the essential properties and applications of Boc-(R)-3-Amino-4-(4-bromophenyl)-butyric Acid, a critical building block for advanced pharmaceutical synthesis. Trusted by researchers and manufacturers worldwide.

Get a Quote & Sample

Advantages of Sourcing Our Pharmaceutical Intermediates

Exceptional Purity and Quality

Our Boc-(R)-3-Amino-4-(4-bromophenyl)-butyric Acid consistently meets stringent purity standards, vital for pharmaceutical applications. As a dedicated supplier, we prioritize quality control to ensure product efficacy and safety.

Consistent Supply Chain Management

We understand the importance of supply chain stability for our B2B clients. Partner with us to buy this key intermediate, ensuring timely delivery and consistent availability from our manufacturing facilities.

Expertise in Fine Chemical Synthesis

Leveraging our advanced manufacturing capabilities, we provide expert synthesis of specialized chemical compounds like Boc-(R)-3-Amino-4-(4-bromophenyl)-butyric Acid. Get a competitive price for this critical pharmaceutical intermediate by contacting our sales team.

Key Applications in Pharmaceutical Development

Pharmaceutical Synthesis

This compound serves as a fundamental chiral building block in the synthesis of a wide range of active pharmaceutical ingredients (APIs), enabling the creation of advanced therapeutics.

Drug Discovery Research

Researchers rely on high-quality intermediates like Boc-(R)-3-Amino-4-(4-bromophenyl)-butyric Acid to explore new chemical entities and develop innovative drug candidates.

Custom Peptide Synthesis

As an N-Boc protected amino acid derivative, it is valuable in custom peptide synthesis, contributing to the development of peptide-based drugs and research tools.

Organic Synthesis

Its unique chemical structure, featuring a bromine atom and a chiral center, makes it a versatile reagent in various complex organic synthesis pathways for fine chemicals.